Latest Conference Articles

What attendees can expect at the 2021 virtual Angiogenesis meeting

What attendees can expect at the 2021 virtual Angiogenesis meeting

January 28th 2021

Angiogenesis

Annual Bascom Palmer Eye Institute program will spotlight latest advances in neovascular and exudative ocular disease over 2-day event, February 12-13.

Angiogenesis 2021: Imaging among the focal points for February 12 agenda

Angiogenesis 2021: Imaging among the focal points for February 12 agenda

January 28th 2021

Angiogenesis

Three sessions cover the range from clinical updates for imaging to emerging therapies for non-exudative AMD.

Angiogenesis 2021: February 13 agenda takes on AMD, DME, DR, gene therapy

Angiogenesis 2021: February 13 agenda takes on AMD, DME, DR, gene therapy

January 28th 2021

Angiogenesis

The program features an update on faricimab, plus diabetes, choroiditis, retinitis pigmentosa, and late-breaking reports.

Safety and efficacy of KPI-121 0.25% for DED treatment

Safety and efficacy of KPI-121 0.25% for DED treatment

December 18th 2020

AAO

Preeya Gupta, MD, discusses the results of a study evaluating the safety and efficacy of KPI-121 0.25% for the treatment of dry eye disease.

Analyzing an investigational ophthalmic solution for treating presbyopia-related symptoms

Analyzing an investigational ophthalmic solution for treating presbyopia-related symptoms

December 13th 2020

AAO

Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.

Evaluating long-term safety of micro-bypass implant + phaco in PXG

Evaluating long-term safety of micro-bypass implant + phaco in PXG

December 12th 2020

AAO

Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.

Violet light-filtering IOLs: visual and non-visual benefits

Violet light-filtering IOLs: visual and non-visual benefits

December 10th 2020

AAO

Daniel H. Chang, MD, speaks on the highlights of his presentation on "Violet Light-Filtering IOLs: Visual and Non-Visual Benefits," during the virtual AAO 2020 meeting.

Drug delivery vs drops: Controlling postop pain, inflammation in cataract patients

Drug delivery vs drops: Controlling postop pain, inflammation in cataract patients

December 8th 2020

AAO

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.

Single administration of intracameral bimatoprost implant: IOP lowering, safety

Single administration of intracameral bimatoprost implant: IOP lowering, safety

December 2nd 2020

AAO

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

AAO 2020: Comparing outcomes of xen gel stents in glaucoma practice

AAO 2020: Comparing outcomes of xen gel stents in glaucoma practice

November 28th 2020

AAO

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.